Topics covered:
- Optimizing your DNA template sequence for in vitro transcription (IVT)
- Streamlining plasmid DNA preparation using the Cloning Kit for mRNA Template
- Maximizing mRNA yield using the Takara IVTpro T7 mRNA Synthesis System
Guest webinar
Streamlining your IVT workflow to maximize mRNA yields, from template design to synthesis
The recent pandemic highlighted the speed and flexibility of synthetic mRNA as a platform for vaccine development. These early successes paved the way for a revolutionary future of RNA-based therapies.
In this webinar, Dr. Tarik Hadi discusses Takara Bio’s unique end-to-end solution that generates ultra-high yields of synthetic mRNA with minimal time and reagents. Register below to access the on-demand webinar.
Webinar outline
Meet the presenter
Tarik Hadi, PhD
Dr. Tarik Hadi has been the European Market Strategy Manager for Vaccine Development since 2021 and manages Takara Bio’s cloning and IVT products. Dr. Hadi obtained his PhD in Molecular Biology at the University of Burgundy in 2013, identifying new vectorization strategies of immunotherapeutic drugs for colorectal cancer treatment. Prior to joining Takara, Dr. Hadi worked at New York University’s Langone Medical Center as a postdoctoral researcher, where he uncovered crosstalk between immune and vascular cells during the development of abdominal aortic aneurysms.
Takara Bio USA, Inc.
United States/Canada: +1.800.662.2566 • Asia Pacific: +1.650.919.7300 • Europe: +33.(0)1.3904.6880 • Japan: +81.(0)77.565.6999
FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES. © 2025 Takara Bio Inc. All Rights Reserved. All trademarks are the property of Takara Bio Inc. or its affiliate(s) in the U.S. and/or other countries or their respective owners. Certain trademarks may not be registered in all jurisdictions. Additional product, intellectual property, and restricted use information is available at takarabio.com.
